We've found
					52,953 Cancer				
					clinical trials				
				
			
		
							
  	
	Oncology Clinical Trial
	Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Epithelial Ovarian Cancer Clinical Trial
	Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Epithelial Ovarian Cancer Clinical Trial
	Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Epithelial Ovarian Cancer Clinical Trial
	Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non-Small Cell Lung Cancer Clinical Trial
	A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non-Small Cell Lung Cancer Clinical Trial
	A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non-Small Cell Lung Cancer Clinical Trial
	A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Nephrology / Urology, Oncology Clinical Trial
	Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Pancreatic Cancer Clinical Trial
	TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Pancreatic Cancer Clinical Trial
	TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Prostate Cancer Clinical Trial
	A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Prostate Cancer Clinical Trial
	A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Prostate Cancer Clinical Trial
	A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Prostate Cancer Clinical Trial
	A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Prostate Cancer Clinical Trial
	A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Advanced Cancer Clinical Trial
	A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Advanced Cancer Clinical Trial
	A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Advanced Cancer Clinical Trial
	A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non Small Cell Lung Cancer Clinical Trial
	A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Advanced Solid Tumors Clinical Trial
	A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Advanced Solid Tumors Clinical Trial
	A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Oncology Clinical Trial
	Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Oncology Clinical Trial
	Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
						
				
			
We've found
					52,953 Cancer
				
					clinical trials
				
				
				
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Epithelial Ovarian Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Epithelial Ovarian Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Epithelial Ovarian Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non-Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non-Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non-Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Nephrology / Urology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Pancreatic Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Pancreatic Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Prostate Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Prostate Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Prostate Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Prostate Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Prostate Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Advanced Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Advanced Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Advanced Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Advanced Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Advanced Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials